Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Por um escritor misterioso
Descrição
Targeting cancer stem cells for reversing therapy resistance
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer
Acquired resistance for immune checkpoint inhibitors in cancer
Tenulin and isotenulin inhibit P-glycoprotein function and
The Effects of Traditional Chinese Medicine on P-Glycoprotein
Role of natural P-gp inhibitor in the effective delivery for
Multidrug resistance in cancer: role of ATP–dependent transporters
Emerging nanotechnology-based therapeutics to combat multidrug
Nanoparticle-based combination therapy for ovarian cancer
Advances in understanding the role of P-gp in doxorubicin
Multidrug resistance in chronic myeloid leukemia. P-glycoprotein
Advances in understanding the role of P-gp in doxorubicin
Frontiers DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes
Approaches to minimize the effects of P‐glycoprotein in drug
Emerging nanotechnology-based therapeutics to combat multidrug
de
por adulto (o preço varia de acordo com o tamanho do grupo)
